|
LCORL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77789999999955E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.364700E-04 |
| Normal-vs-Stage2 |
1.044710E-03 |
| Normal-vs-Stage3 |
1.52515999999325E-05 |
| Normal-vs-Stage4 |
9.796900E-04 |
| Stage1-vs-Stage2 |
6.319600E-01 |
| Stage1-vs-Stage3 |
8.751700E-02 |
| Stage1-vs-Stage4 |
4.198400E-01 |
| Stage2-vs-Stage3 |
3.184800E-01 |
| Stage2-vs-Stage4 |
4.643800E-01 |
| Stage3-vs-Stage4 |
9.963200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.87259999995248E-06 |
| Normal-vs-AfricanAmerican |
5.417900E-02 |
| Normal-vs-Asian |
2.896400E-03 |
| Caucasian-vs-AfricanAmerican |
3.253400E-01 |
| Caucasian-vs-Asian |
5.786600E-01 |
| AfricanAmerican-vs-Asian |
5.076400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59469999982953E-07 |
| Normal-vs-Female |
2.639400E-01 |
| Male-vs-Female |
5.723600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.426090E-02 |
| Normal-vs-Extreme_Weight |
5.29510000291111E-08 |
| Normal-vs-Obese |
1.970010E-02 |
| Normal-vs-Extreme_Obese |
6.544200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.101600E-01 |
| Normal_Weight-vs-Obese |
4.599000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.021600E-01 |
| Extreme_Weight-vs-Obese |
9.215300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.174800E-01 |
| Obese-vs-Extreme_Obese |
7.866400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.419000E-03 |
| Normal-vs-Age(41-60Yrs) |
6.595600E-04 |
| Normal-vs-Age(61-80Yrs) |
2.25029999999515E-05 |
| Normal-vs-Age(81-100Yrs) |
1.02300000004441E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.459200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.922200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.466200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.495200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.791500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.531500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.31760000033188E-07 |
| Normal-VS-Type2 PRCC |
7.981600E-03 |
| Normal-VS-KIRP CIMP |
1.932410E-02 |
| Normal-VS-Unclassified PRCC |
2.236200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.057800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.707600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.031800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.224800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.421400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.203600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.63990000004544E-06 |
| Normal-vs-N1 |
7.70039999999916E-05 |
| Normal-vs-N2 |
3.653900E-02 |
| N0-vs-N1 |
9.992200E-01 |
| N0-vs-N2 |
8.695200E-01 |
| N1-vs-N2 |
8.783400E-01 |
|
|
